Indefinite Delivery Contract 36E79723D0005
Award Date
1/15/23
Last Date to Order
1/14/26
Federal Agency
National Acquisition Center
Awardee
Sandoz Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The federal government, through the National Acquisition Center (NAC) of the Department of Veterans Affairs (VA), has awarded a single-award Indefinite Delivery Contract (IDC) to Sandoz Inc., a global pharmaceutical company, to provide a variety of prescription medications. The $7,402,374.05 contract has a base period of one year and four one-year option periods, with an ultimate completion date of January 14, 2026. The contract aims to procure Amoxicillin/Clavulanate Tablets to meet the...
The federal government has awarded an Indefinite Delivery Contract to Sandoz Inc., a global leader in generic pharmaceuticals and biosimilars, to supply a variety of prescription medications through the VA and DoD pharmaceutical prime vendor programs. The contract, valued up to $164,608.40, has a base year plus four one-year option periods, and aims to meet the medication needs of veterans, active duty military personnel, federal inmates, and Native American populations served by the...
The U.S. Department of Veterans Affairs (VA) has awarded Sandoz Inc., a Novartis subsidiary, an indefinite delivery vehicle (IDV) under the Federal Supply Schedule for Pharmaceuticals and Drugs (FSS-61-IB). The contract, valued at $16.85 billion, allows the VA, Department of Defense, Bureau of Prisons, and Indian Health Services to order a variety of pharmaceutical products from Sandoz's commercial catalog, including antibiotics, chemotherapy drugs, ophthalmic solutions, psychiatric medications,...
This federal contract IDV is a multiple award Federal Supply Schedule (FSS) contract awarded by the Department of Veterans Affairs (VA) to Sandoz Inc., a global leader in generic pharmaceuticals and biosimilars. The contract, which has a ceiling value of $683,208,960.00 and a period of performance through August 2028, is for the provision of a variety of prescription medications to VA medical centers, the Department of Defense (DoD), Bureau of Prisons, and Indian Health Services facilities....
The Department of Veterans Affairs (VA) National Acquisition Center awarded a single-award Indefinite Delivery Contract (IDC) to Sandoz Inc., a global leader in generic pharmaceuticals and biosimilars. The IDC, valued at a ceiling of $236,745.90, is for the supply of TRIFLUOPERAZINE tablets to the VA, Department of Defense (DoD), Bureau of Prisons (BOP), and Indian Health Service (IHS) healthcare networks. The contract has a base period of one year, with four one-year option periods, and...
The National Acquisition Center, a civilian agency within the Department of Veterans Affairs, has awarded an Indefinite Delivery Contract to Sandoz Inc., a global pharmaceutical company, to supply Latanoprost Ophthalmic Solution for the VA, DoD, Bureau of Prisons, and Indian Health Service. This single-award contract has a ceiling value of $23,010,467.85 and a period of performance from March 21, 2022, to March 20, 2023, with four 1-year option periods. The contract aims to provide an...
The Department of Veterans Affairs National Acquisition Center awarded an indefinite delivery contract to Sandoz Inc. for the delivery of amitriptyline hydrochloride tablets. The single award contract has a potential value of $14.1 million over a one year base period and four one year option periods extending to March 6, 2023. The originating pre-solicitation notice sought offers for an unrestricted procurement to supply amitriptyline hydrochloride tablets to meet the estimated annual...
The Federal Supply Schedule contract awarded to Mylan Pharmaceuticals Inc. by the Department of Veterans Affairs National Acquisition Center (VA NAC) provides a range of pharmaceutical and hematology-related products to VA healthcare facilities, the Department of Defense, Bureau of Prisons, and Indian Health Service locations nationwide. The contract, valued at up to $364,546,690 over its 5-year period of performance, covers a diverse portfolio of drug products including specialty medications...
The Department of Veterans Affairs National Acquisition Center awarded a single-award Indefinite Delivery Contract to Baxter Healthcare Corporation on October 15, 2020, with a potential value of $30,336,036.80. The contract provides for the supply of cyclophosphamide vial injections in 1gm, 2gm, and 500mg sizes to the VA, DOD, BOP and IHS. The pre-solicitation notice indicated annual estimated requirements totaling over 12,000 vials across the three sizes, ranging from over 4,000 to 5,486...
The federal contract IDV award is a single award Indefinite Delivery Contract between the Department of Veterans Affairs (VA) National Acquisition Center and Sandoz Inc., a global pharmaceutical company, to provide a variety of prescription medications through the VA and Department of Defense (DoD) pharmaceutical prime vendor programs. The contract has a base period of performance from May 30, 2021 to May 29, 2022 with four one-year option periods, and a ceiling value of $9,803,319.55. The...